FC
BMY icon

Forte Capital’s Bristol-Myers Squibb BMY Stock Holding History

Forte Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,963
Closed -$215K – 232
2024
Q1 		$215K Sell
3,963
-60
-1% -$3.06K 0.03% 228
2023
Q4 		$206K Sell
4,023
-978
-20% -$51.3K 0.03% 221
2023
Q3 		$290K Sell
5,001
-125
-2% -$7.66K 0.04% 176
2023
Q2 		$328K Sell
5,126
-541
-10% -$36.3K 0.05% 167
2023
Q1 		$393K Hold
5,667
– – 0.06% 152
2022
Q4 		$408K Buy
5,667
+790
+16% +$59.6K 0.07% 146
2022
Q3 		$347K Buy
4,877
+566
+13% +$41.1K 0.06% 153
2022
Q2 		$332K Buy
4,311
+8
+0.2% +$609 0.06% 154
2022
Q1 		$268K Hold
4,303
– – 0.03% 201
2021
Q4 		$268K Sell
4,303
-1,337
-24% -$78.4K 0.03% 201
2021
Q3 		$334K Buy
5,640
+37
+0.7% +$2.44K 0.05% 173
2021
Q2 		$374K Buy
5,603
+192
+4% +$12.5K 0.05% 168
2021
Q1 		$342K Sell
5,411
-902
-14% -$56.1K 0.05% 164
2020
Q4 		$392K Sell
6,313
-164
-3% -$10.1K 0.06% 154
2020
Q3 		$391K Sell
6,477
-161
-2% -$9.69K 0.07% 141
2020
Q2 		$390K Buy
+6,638
New +$397K 0.08% 131
2017
Q4 		– Sell
-3,593
Closed -$229K – 165
2017
Q3 		$229K Buy
+3,593
New +$210K 0.07% 149
2016
Q2 		– Sell
-3,904
Closed -$249K – 154
2016
Q1 		$249K Sell
3,904
-50
-1% -$3.15K 0.11% 136
2015
Q4 		$272K Sell
3,954
-85
-2% -$5.62K 0.11% 135
2015
Q3 		$239K Sell
4,039
-1,100
-21% -$69.8K 0.11% 139
2015
Q2 		$342K Sell
5,139
-50
-1% -$3.29K 0.15% 131
2015
Q1 		$341K Hold
5,189
– – 0.15% 127
2014
Q4 		$306K Sell
5,189
-300
-5% -$16.9K 0.13% 129
2014
Q3 		$281K Buy
+5,489
New +$274K 0.13% 133

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Forte Capital's BMY Position: Q2 2024 in Review

Forte Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 3,963 shares — an estimated $215K sold.

Forte Capital first reported a position in BMY in Q3 2014 and held it in 24 quarters. The position peaked at $408K in Q4 2022. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Forte Capital reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Forte Capital sold 3,963 Bristol-Myers Squibb shares in Q2 2024, an estimated $215K.
  • Forte Capital first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 24 quarters.
  • Forte Capital's Bristol-Myers Squibb position peaked at $408K in Q4 2022.
  • 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Forte Capital's 13F filing for Q2 2024, filed 13 Aug 2024.